Search
All Clinical Trials in United Kingdom
A listing of 3097 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
145 - 156 of 3097
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery
Recruiting
Axillary ultrasound scan (AUS) is routinely employed in the UK for preoperative axillary staging and can diagnose approximately 50 - 80% of node positive patients when combined with percutaneous needle biopsy techniques (either core-biopsy or fine-needle aspiration cytology). It is recognised that nodal burden is generally higher in clinically node negative patients with abnormal nodes on AUS and confirmed on needle-biopsy to be histologically positive than patients diagnosed as node positive on... Read More
Axillary ultrasound scan (AUS) is routinely employed in the UK for preoperative axillary staging and can diagnose approximately 50 - 80% of node positive patients when combined with percutaneous needle biopsy techniques (either core-biopsy or fine-needle aspiration cytology). It is recognised that nodal burden is generally higher in clinically node negative patients with abnormal nodes on AUS and confirmed on needle-biopsy to be histologically positive than patients diagnosed as node positive on sentinel node biopsy (SNB). However, up to 40% of biopsy-proven node positive patients are found to have fewer than 3 involved nodes on subsequent axillary lymph node dissection (ALND) and are potential candidates for less extensive axillary surgery with axillary radiotherapy (ART) rather than ALND. The total number of abnormal nodes on ultrasound is a key predictor of overall nodal tumour burden.
The AMAROS and OTOASOR trials randomised patients with up to 2 positive sentinel nodes to either ALND or ART. These trials were conducted around the turn of the millennium and before routine use of AUS and therefore would have included a significant number of patients who were radiologically node positive (cN1). Likewise, the ACOSOG Z0011 trial that randomised a similar group of patients to either ALND or observation only, did not incorporate routine AUS and would have included some (radiological) cN1 patients. These trials revealed no adverse impact on disease-free or overall survival from omission of completion ALND.
Targeted axillary dissection (TAD) was introduced a few years ago to reduce the false negative rate of SNB following neoadjuvant chemotherapy (NACT) and has been standardised as part of the ongoing ATNEC trial \[ClinicalTrials.govNCT04109079\]. This technique for axillary staging after NACT is increasingly being adopted in the UK and elsewhere. TAD is technically more straightforward and less challenging in patients undergoing primary surgery with no concerns about clip migration consequent to nodal shrinkage as part of treatment response to NACT. Furthermore, the risk of under-treating the axilla is offset by the protocol: if no disease is identified in the targeted nodes (false-negative case), then patients proceed to ALND, thereby ensuring adequate treatment. Unlike TAD following NACT, the presence of viable tumour within the sampled nodes is mandatory and finding fibrosis is irrelevant except as a response to nodal biopsy per se.
Current ASCO guidelines support both SNB and TAD as staging options for patients with ultrasound-detected, biopsy-confirmed nodal disease. The Edinburgh randomised trials comparing four-node sampling with ALND demonstrated significantly lower arm morbidity with node sampling, supporting TAD as a clinically appropriate alternative in this patient population.
The UK-ANZ POSNOC trial randomised 1,900 patients with \<3 macrometastases to either no further axillary treatment or additional axillary treatment. The study included cN1 patients with biopsy-confirmed nodal metastases who underwent sentinel node biopsy or TAD. Patients with \<3 macrometastases on final histology were randomised to receive no further axillary treatment or proceed with additional axillary treatment (ALND or ART). POSNOC trial will answer whether further axillary treatment provides any benefit in patients with low volume nodal disease on SNB or TAD.
Notably, patients with biopsy-confirmed metastases and \<3 macrometastases on SNB/TAD are biologically and clinically similar to patients with normal AUS who are later found to have low-volume disease on SNB. Clinical decision-making and patient outcomes are driven by tumour biology and overall disease burden rather than the method of nodal disease detection. Furthermore, AUS sensitivity is operator dependent and whether FNA or core biopsy was used to sample the node. A patient considered node negative on AUS by one radiologist may be diagnosed with core biopsy confirmed nodal metastases with another radiologist. Pending the results of POSNOC trial, patients with less than 3 macrometastases are generally advised further axillary treatment, and ART is preferred over ALND to reduce the risk of lymphoedema.
NodeSMART is a prospective audit collecting data on all patients undergoing TAD in the primary surgery setting. Its goal is to audit surgical outcomes and benchmark them against - a) Comparing technical outcomes with those from sentinel node biopsy in the primary surgery setting and TAD performed after neoadjuvant chemotherapy. b) Assessing rates of arm lymphoedema and disease progression relative to findings from the AMAROS and Z11 trials, and the POSNOC trial once results are available. The term "Targeted Axillary Dissection" is somewhat misleading in this context, as the marked (biopsied) node is removed alongside sentinel nodes - not in isolation. NodeSMART therefore refers to the procedure more accurately as Targeted Sentinel Node Biopsy (TSNB). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: Burnley General Teaching Hospital, Burnley, Not set +4 locations
Burnley General Teaching Hospital, Burnley, Not set
Addenbrooke's Hospital, Cambridge, Not set
Royal Derby Hospital, Derby, Not set
NHS Greater Glasgow and Clyde, Glasgow, Not set
Mersey and West Lancashire Teaching Hospitals, St Helens, Not set
Conditions: Breast Cancer, Axillary Lymph Nodes Dissection, Axillary Metastases, Sentinel Lymph Node Biopsy (SLNB), Node Positive Breast Cancer, Axilla; Breast, Axillary Ultrasound
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Recruiting
The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.
The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC. Read Less
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
08/18/2025
Locations: Research Site, Scottsdale, Arizona +254 locations
Research Site, Scottsdale, Arizona
Research Site, Tucson, Arizona
Research Site, Tucson, Arizona
Research Site, Fullerton, California
Research Site, La Jolla, California
Research Site, Los Alamitos, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, San Francisco, California
Research Site, Fort Myers, Florida
Research Site, Jacksonville, Florida
Research Site, Saint Petersburg, Florida
Research Site, Tampa, Florida
Research Site, West Palm Beach, Florida
Research Site, Atlanta, Georgia
Research Site, Coeur d'Alene, Idaho
Research Site, Chicago, Illinois
Research Site, Niles, Illinois
Research Site, Towson, Maryland
Research Site, Worcester, Massachusetts
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Rochester, Minnesota
Research Site, Kansas City, Missouri
Research Site, Saint Louis, Missouri
Research Site, Albuquerque, New Mexico
Research Site, New York, New York
Research Site, Cleveland, Ohio
Research Site, Columbus, Ohio
Research Site, Greenville, South Carolina
Research Site, Nashville, Tennessee
Research Site, Austin, Texas
Research Site, Dallas, Texas
Research Site, Fort Worth, Texas
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Pearland, Texas
Research Site, San Antonio, Texas
Research Site, San Antonio, Texas
Research Site, Fairfax, Virginia
Research Site, Chermside, Not set
Research Site, Clayton, Not set
Research Site, Concord, Not set
Research Site, Nedlands, Not set
Research Site, Graz, Not set
Research Site, Linz, Not set
Research Site, Salzburg, Not set
Research Site, Wiener Neustadt, Not set
Research Site, Wien, Not set
Research Site, Anderlecht, Not set
Research Site, Edegem, Not set
Research Site, Gent, Not set
Research Site, Leuven, Not set
Research Site, Liège, Not set
Research Site, Roeselare, Not set
Research Site, Natal, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Santa Maria, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Vitória, Not set
Research Site, Edmonton, Alberta
Research Site, Halifax, Nova Scotia
Research Site, Brampton, Ontario
Research Site, Toronto, Ontario
Research Site, Montréal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changde, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Fuzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Guiyang, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Luoyang, Not set
Research Site, Nanchang, Not set
Research Site, Nanning, Not set
Research Site, Nantong, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Tianjin, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Brno, Not set
Research Site, Brno, Not set
Research Site, Hradec Kralove, Not set
Research Site, Olomouc, Not set
Research Site, Praha 10, Not set
Research Site, Praha 5, Not set
Research Site, Brest, Not set
Research Site, Clichy Cedex, Not set
Research Site, Dijon, Not set
Research Site, Lille, Not set
Research Site, Lyon, Not set
Research Site, Marseille, Not set
Research Site, Montpellier, Not set
Research Site, Nimes, Not set
Research Site, Pessac, Not set
Research Site, Villejuif, Not set
Research Site, Berlin, Not set
Research Site, Bonn, Not set
Research Site, Dresden, Not set
Research Site, Frankfurt, Not set
Research Site, Freiburg, Not set
Research Site, Göttingen, Not set
Research Site, Hamburg, Not set
Research Site, Köln, Not set
Research Site, Leipzig, Not set
Research Site, Lübeck, Not set
Research Site, Munchen, Not set
Research Site, Ulm, Not set
Research Site, Würzburg, Not set
Research Site, Hong Kong, Not set
Research Site, Shatin, Not set
Research Site, Dehradun, Not set
Research Site, Delhi, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Kolkata, Not set
Research Site, Mumbai, Not set
Research Site, Vadodara, Not set
Research Site, Varanasi, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Naples, Not set
Research Site, Napoli, Not set
Research Site, Padova, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Tricase, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chiba-shi, Not set
Research Site, Fukuyama-shi, Not set
Research Site, Hirakata-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kanazawa, Not set
Research Site, Kashiwa, Not set
Research Site, Kawasaki-shi, Not set
Research Site, Kita-gun, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Maebashi-shi, Not set
Research Site, Mitaka-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka, Not set
Research Site, Sakai-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Suita-city, Not set
Research Site, Sunto-gun, Not set
Research Site, Ube-shi, Not set
Research Site, Wakayama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Busan, Not set
Research Site, Gyeonggi-do, Not set
Research Site, Hwasun-gun, Not set
Research Site, Seongnam-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, George Town, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuching, Not set
Research Site, Rotterdam, Not set
Research Site, Cebu City, Not set
Research Site, Makati, Not set
Research Site, Pasig City, Not set
Research Site, Quezon City, Not set
Research Site, Białystok, Not set
Research Site, Katowice, Not set
Research Site, Kraków, Not set
Research Site, Lublin, Not set
Research Site, Warszawa, Not set
Research Site, Wrocław, Not set
Research Site, Ar Riyāḑ, Not set
Research Site, Dammam, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Banska Bystrica, Not set
Research Site, Bratislava, Not set
Research Site, Kosice, Not set
Research Site, Martin, Not set
Research Site, Trnava, Not set
Research Site, Barcelona, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Málaga, Not set
Research Site, Santander, Not set
Research Site, Kaohsiung City, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Taipei 112, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Hat Yai, Not set
Research Site, Khon Kaen, Not set
Research Site, Muang, Not set
Research Site, Mueang, Not set
Research Site, Naimuang, Not set
Research Site, Ongkharak, Not set
Research Site, Sisaket, Not set
Research Site, Altındağ, Not set
Research Site, Antalya, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Research Site, Mezitli, Not set
Research Site, Yakutiye, Not set
Research Site, Birmingham, Not set
Research Site, Dundee, Not set
Research Site, Glasgow, Not set
Research Site, Greater London, Not set
Research Site, Leeds, Not set
Research Site, London, Not set
Research Site, Hanoi, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh city, Not set
Research Site, Ho Chi Minh City, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Vinh, Not set
Conditions: Biliary Tract Cancer
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Recruiting
A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating. The headache is often accompanied by sensitivity to light, sensitivity to sound, nausea, or other symptoms. Menstrual migraine (MM) attacks are migraine attacks that occur in individuals before or during their menstrual period. The main goals of the study are to evaluate the efficacy (how well the medicine works), safety, and tolerability (the degree to which any ad... Read More
A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating. The headache is often accompanied by sensitivity to light, sensitivity to sound, nausea, or other symptoms. Menstrual migraine (MM) attacks are migraine attacks that occur in individuals before or during their menstrual period. The main goals of the study are to evaluate the efficacy (how well the medicine works), safety, and tolerability (the degree to which any adverse symptoms can be handled by the patients during the study) of atogepant, compared to placebo (looks like the study treatment but has no medicine in it), for the prevention of MM.
Atogepant is an investigational drug being developed for the preventive treatment of menstrual migraine. Participants are randomly assigned to one of the 2 treatment groups called Arms to receive atogepant or matching placebo. There is 1 in a 2 chance for the participant to receive placebo. Approximately 430 adult female participants with menstrual migraine will be enrolled in approximately 85 sites across the world.
Participants will receive oral atogepant or matching placebo for 3 menstrual cycles during the double-blind period. During the open-label treatment period, participants will receive atogepant during each menstrual cycle.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The safety and tolerability of the treatment will be checked by medical assessments, blood tests, checking for adverse events and completing questionnaires. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: Chinese PLA General Hospital /ID# 267141, Beijing, Beijing +88 locations
Chinese PLA General Hospital /ID# 267141, Beijing, Beijing
Nanfang Hospital - Southern Medical University /ID# 268510, Guangzhou, Guangdong
Hebei General Hospital /ID# 267663, Shijiazhuang, Hebei
Renmin Hospital of Wuhan University /ID# 267671, Wuhan, Hubei
The First Affiliated Hospital of Soochow University /ID# 267885, Suzhou, Jiangsu
Shaanxi Provincial People'S Hospital /ID# 267827, XI An, Shaanxi
First Affiliated Hospital of Shanxi Medical University /ID# 267680, Taiyuan, Shanxi
Tianjin Medical University General Hospital /ID# 268846, Tianjin, Tianjin
Tianjin People's Hospital /ID# 268511, Tianjin, Tianjin
The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 267994, Hangzhou, Zhejiang
A-Shine s.r.o. /ID# 266048, Plzen, Plzensky Kraj
Všeobecná Fakultní Nemocnice v Praze /ID# 268100, Praha, Praha 17
MINKSneuro s.r.o /ID# 267651, Brno, Not set
Neurologie Brno /ID# 266050, Brno, Not set
NeuroHK s.r.o. /ID# 266051, Hradec Kralove, Not set
Neuro plus s.r.o. /ID# 266052, Olomouc, Not set
Clintrial s.r.o. /ID# 266047, Prague 10, Not set
DADO MEDICAL s.r.o. /ID# 267629, Prague, Not set
Pratia Prague s.r.o. /ID# 268252, Prague, Not set
Fakultni Thomayerova nemocnice /ID# 266049, Praha, Not set
Neuro Centrum Odenwald - Praxis Erbach /ID# 276171, Erbach, Hessen
Universitaetsmedizin Greifswald /ID# 267277, Greifswald, Mecklenburg-Vorpommern
Studienzentrum Nord-West /ID# 267311, Westerstede, Niedersachsen
Neurozentrum Bielefeld /ID# 276170, Bielefeld, Nordrhein-Westfalen
Klinikum Ibbenbueren /ID# 267393, Ibbenbüren, Nordrhein-Westfalen
ZNS Siegen /ID# 268247, Siegen, Nordrhein-Westfalen
Pharmakologisches Studienzentrum Chemnitz GmbH /ID# 267285, Chemnitz, Sachsen
Ambenet Hausarztpraxis /ID# 267309, Leipzig, Sachsen
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 267310, Berlin, Not set
MIND Clinic /ID# 267652, Budapest, Not set
Cortex Study Center /ID# 266639, Budapest, Not set
Clinexpert Kft /ID# 266644, Budapest, Not set
Semmelweis Egyetem /ID# 266636, Budapest, Not set
Semmelweis Egyetem /ID# 266752, Budapest, Not set
UNO Medical Trials /ID# 266643, Budapest, Not set
S-Medicon Kft /ID# 266637, Budapest, Not set
Uzsoki Utcai Kórház /ID# 266641, Budapest, Not set
Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 267062, Milan, Milano
Istituto Auxologico Italiano - Ospedale San Luca /ID# 276161, Milan, Milano
Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 267023, Naples, Napoli
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 266859, Rome, Roma
ICOT Istituto Marco Pasquali /ID# 267288, Latina, Not set
Fondazione Mondino Istituto Neurologico Nazionale a Carattere Scientifico IRCCS /ID# 267922, Pavia, Not set
Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia /ID# 267926, Perugia, Not set
ASU FC - P.O. Universitario Santa Maria della Misericordia /ID# 267019, Udine, Not set
Konan Medical Center /ID# 266867, Kobe-shi, Hyogo
Fujitsu Clinic /ID# 266877, Kawasaki-shi, Kanagawa
Umenotsuji Clinic /ID# 266834, Kochi-shi, Kochi
Sendai Headache and Neurology Clinic Medical Corporation /ID# 266864, Sendai-shi, Miyagi
Ooba Clinic for Neurosurgery & Headache /ID# 266866, Oita-shi, Oita
Chibune General Hospital /ID# 266874, Osaka-shi, Osaka
Tominaga Clinic - Osaka /ID# 268228, Osaka-shi, Osaka
Usuda Clinic Of Internal Medicine /ID# 266870, Setagaya-ku, Tokyo
Tokyo Headache Clinic /ID# 266863, Shibuya-ku, Tokyo
Nagaseki Headache Clinic /ID# 266865, Kai, Yamanashi
Hallym University Dongtan Sacred Heart Hospital /ID# 267473, Hwaseong, Gyeonggido
Nowon Eulji Medical Center, Eulji University /ID# 267474, Seoul, Seoul Teugbyeolsi
Seoul National University Hospital /ID# 267477, Seoul, Seoul Teugbyeolsi
Kangbuk Samsung Hospital /ID# 267475, Seoul, Seoul Teugbyeolsi
Yonsei University Health System Severance Hospital /ID# 267476, Seoul, Seoul Teugbyeolsi
Athleticomed Sp. z o.o /ID# 266434, Bydgoszcz, Kujawsko-pomorskie
SPZOZ Szpital Uniwersytecki w Krakowie /ID# 266443, Krakow, Malopolskie
Instytut Zdrowia Dr Boczarska Jedynak /ID# 266073, Oświęcim, Malopolskie
Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 266732, Gdansk, Pomorskie
Novo-Med Zielinski i wspolnicy SP. J. /ID# 266433, Katowice, Slaskie
Neuro-Care Sp. z o.o. sp.k /ID# 267883, Katowice, Slaskie
Solumed Centrum Medyczne /ID# 267220, Poznan, Wielkopolskie
MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak /ID# 266437, Wroclaw, Not set
Unidade Local de Saude do Alto Ave, EPE /ID# 266168, Guimaraes, Braga
Hospital da Luz /ID# 266182, Lisbon, Lisboa
Unidade Local de Saude de Loures-Odivelas, EPE /ID# 266190, Loures, Lisboa
Unidade Local de Saude de Matosinhos, EPE /ID# 266170, Senhora da Hora, Porto
Unidade Local de Saude de Almada-Seixal, EPE /ID# 276215, Almada, Setubal
Unidade Local de Saude da Regiao de Aveiro, EPE /ID# 266187, Aveiro, Not set
2CA-Braga, Hospital de Braga /ID# 276218, Braga, Not set
Unidade Local de Saude de Santa Maria, EPE /ID# 275932, Lisboa, Not set
Unidade Local de Saude Sao Joao, EPE /ID# 266185, Porto, Not set
Unidade Local de Saude da Arrabida, EPE /ID# 266183, Setubal, Not set
Hospital Clinico Universitario de Valladolid /ID# 275899, Valladolid, Not set
China Medical University Hospital /ID# 266423, Taichung, Not set
National Cheng Kung University Hospital /ID# 267754, Tainan, Not set
Mackay Memorial Hospital /ID# 266421, Taipei City, Not set
Taipei Veterans General Hospital /ID# 266418, Taipei City, Not set
Linkou Chang Gung Memorial Hospital /ID# 266424, Taoyuan City, Not set
Royal Sussex County Hospital /ID# 268362, Brighton, East Sussex
St Pancras Clinical Research /ID# 268653, London, Greater London
Breckland Alliance /ID# 268772, Thetford, Norfolk
Oxford University Hospitals - John Radcliffe Hospital /ID# 267659, Oxford, Oxfordshire
The Adam Practice /ID# 268116, Poole, Not set
Conditions: Menstrual Migraine (MM)
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
Recruiting
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population. Read Less
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/18/2025
Locations: Local Institution - 0237, Searcy, Arkansas +206 locations
Local Institution - 0237, Searcy, Arkansas
UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla, California
Local Institution - 0241, San Diego, California
Rheumatology Center of San Diego, San Diego, California
East Bay Rheumatology Medical Group, Inc, San Leandro, California
Providence Saint John's Medical Foundation, Santa Monica, California
Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida
UF Health Deerwood Park, Jacksonville, Florida
Life Clinical Trials, Margate, Florida
Nuline Clinical Trial Center, Oakland Park, Florida
Local Institution - 0239, Plant City, Florida
Emory University School of Medicine- Grady Campus, Atlanta, Georgia
Atlanta Research Center for Rheumatology, Marietta, Georgia
Greater Chicago Specialty Physicians - Orland Park, Orland Park, Illinois
Local Institution - 0041, Skokie, Illinois
Local Institution - 0231, New Orleans, Louisiana
Massachusetts General Hospital, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
University of Massachusetts Chan Medical School, Worcester, Massachusetts
AA Medical Research Center-Grand Blanc, Grand Blanc, Michigan
Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota
Local Institution - 0200, Las Vegas, Nevada
Local Institution - 0216, Las Vegas, Nevada
The Valley Hospital, Inc., Paramus, New Jersey
Joseph S. and Diane H. Steinberg Ambulatory Care Center, Brooklyn, New York
Irving Goldman Family Care Center, Great Neck, New York
Hospital for Special Surgery, New York, New York
Columbia University Medical Center, New York, New York
SUNY Upstate Medical University, Syracuse, New York
Local Institution - 0178, Charlotte, North Carolina
University of Cincinnati Medical Center, Cincinnati, Ohio
University Hospitals Cleveland Medical Center, Cleveland, Ohio
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
Temple University Hospital, Philadelphia, Pennsylvania
West Penn Allegheny Health, Pittsburgh, Pennsylvania
Local Institution - 0081, Charleston, South Carolina
Hope Health, Florence, South Carolina
Local Institution - 0228, Florence, South Carolina
West Tennessee Research Institute, Jackson, Tennessee
Austin Regional Clinic, Austin, Texas
Local Institution - 0001, Colleyville, Texas
Texas Arthritis Center, El Paso, Texas
Biopharma Informatic, LLC, Katy, Texas
Baylor Scott & White Medical Center - Temple, Temple, Texas
Spectrum Medical, Inc., Danville, Virginia
Sanatorio Guemes, Ciudad de Buenos Aires, Buenos Aires
Hospital El Cruce, Florencio Varela, Buenos Aires
Hospital Italiano de La Plata, La Plata, Buenos Aires
Centro de Investigacion Pergamino S.A., Pergamino, Buenos Aires
Hospital Universitario Austral, Pilar, Buenos Aires
Centro de Investigaciones San Miguel, San Miguel, Buenos Aires
CER medical Institute, Quilmes, Ciudad Autónoma De Buenos Aires
Centro de Investigaciones Médicas Tucuman, SAN M. DE Tucuman, Tucumán
Centro Integral de Reumatologia, San Miguel de Tucumán, Tucumán
Local Institution - 0141, Río Cuarto, Not set
Liverpool Hospital, Liverpool, New South Wales
BJC Health, Paramatta, New South Wales
Rheumatology Research Unit, Maroochydore, Queensland
Austin Health - Repatriation Hospital, Ivanhoe, Victoria
RK Will Pty Ltd, Victoria Park, Western Australia
CEDOES, Vitória, Espírito Santo
Local Institution - 0232, Recife, Pernambuco
Hospital Bruno Born, Lajeado, Rio Grande Do Sul
Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul
Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul
Instituto de Pesquisa e Ensino em Saúde - IPES, Porto Velho, Rondônia
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Local Institution - 0095, Santo André, São Paulo
Centro Multidisciplinar de Estudos Clinicos, Sao Bernardo do Campo, São Paulo
Local Institution - 0033, Curitiba, Not set
Hospital São Lucas de Copacabana, Rio de Janeiro, Not set
Hospital Alemao Oswaldo Cruz, São Paulo, Not set
Hospital 9 De Julho, São Paulo, Not set
CEPIC - Centro Paulista de Investigação Clínica, São Paulo, Not set
Diagnostic Consultative Centre (DCC) - Foкus 5, Sofia, Sofia (stolitsa)
University Hospital Kaspela Clinic of Rheumatology, Plovdiv, Not set
Diagnostic Consultative Centre 1 Ruse, Ruse, Not set
Local Institution - 0214, Sofia, Not set
IC La Serena Research, La Serena, Coquimbo
Local Institution - 0099, Valdivia, Los Ríos
Estudios Clinicos CTR, Santiago, Región Metropolitana De Santiago
Biomedica Research Group, Santiago, Región Metropolitana De Santiago
Estudios Clinicos Limitada, Santiago, Región Metropolitana De Santiago
Local Institution - 0044, Santiago, Región Metropolitana De Santiago
Local Institution - 0098, Santiago, Región Metropolitana De Santiago
Pontificia Universidad Catolica de Chile, Santiago, Región Metropolitana De Santiago
Clínica Ensenada, Santiago, Región Metropolitana De Santiago
Local Institution - 0153, Santiago, Not set
INREA s.r.o., Ostrava, Ostrava Město
Revmatologicky ustav, Praha 2, Not set
General Hospital of Athens Hippokratio, Athens, Attikí (Region)
General Hospital of Athens "Laiko", Athens, Attikí
University General Hospital of Larissa, Larissa, Thessalía
Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya
Békés Vármegyei Központi Kórház Pándy Kálmán Tagkórház, Gyula, Békés
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, Csongrád
Vital Medical Center, Veszprem, Veszprém City
Local Institution - 0197, New Delhi, Delhi
Local Institution - 0234, Ahmedabad, Gujarat
Local Institution - 0209, Ahmedabad, Gujarat
Ratan Multi-Speciality Hospital, Ahmedabad, Gujarat
Sushruta Multispeciality Hospital & Research Centre, Hubli, Karnataka
JSS Hospital, Mysore, Karnataka
Jasleen Hospital, Nagpur, Maharashtra
Christian Medical College Vellore, Vellore, Tamil Nadu
Local Institution - 0204, Vellore, Tamil Nadu
Local Institution - 0235, Hyderabad, Telangana
Krishna Institute of Medical Science, Secundarabad, Telangana
Koujunkai Daido Clinic, Nagoya, Aichi
Local Institution - 0156, Nagoya, Aichi
Fujita Health University, Toyoake, Aichi
Local Institution - 0086, Eiheiji-cho,Yoshida-gun, Fukui
University of Occupational and Enviromental Health, Kitakyushu, Fukuoka
National Hospital Organization Asahikawa Medical Center, Asahikawa, Hokkaido
Hokkaido University Hospital, Sapporo, Hokkaido
Kagawa University Hospital, Kita, Kagawa
Kitasato University Hospital, Sagamihara, Kanagawa
Yokohama City University Hospital, Yokohama, Kanagawa
Tohoku University Hospital, Sendai-shi, Miyagi
Sasebo Chuo Hospital, Sasebo, Nagasaki
Saitama Medical Center, Kawagoe, Saitama
Dokkyo Medical University Hospital, Shimotsuga, Tochigi
Juntendo University Hospital, Bunkyo-ku, Tokyo
Tokyo Medical and Dental University Hospital, Bunkyo-ku, Tokyo
Toho University Ohashi Medical Center, Meguro-ku, Tokyo
Center Hospital of the National Center for Global Health and Medicine, Shinjyuku-ku, Tokyo
Toyama University Hospital, Toyoma, Toyama
National Hospital Organization Chibahigashi National Hospital, Chiba, Not set
Kyushu University Hospital, Fukuoka, Not set
Fukushima Medical University, Fukushima, Not set
Gifu University Hospital, Gifu, Not set
Nagasaki University Hospital, Nagasaki, Not set
Niigata University Medical & Dental Hospital, Niigata, Not set
Okayama University Hospital, Okayama, Not set
Osaka Metropolitan University Hospital, Osaka, Not set
St. Luke's International Hospital, Tokyo, Not set
Keio university hospital, Tokyo, Not set
Wakayama Medical University Hospital, Wakayama, Not set
CIMAB SA de CV, Torreón, Coahuila
Local Institution - 0015, Cdmx, Distrito Federal
RM Pharma Specialists, Mexico city, Distrito Federal
CAIMED Investigacion en Salud, Mexico City, Distrito Federal
Centro de Investigacion Farmacologica del Bajio SC, Leon, Guanajuato
Boca Clinical Trials Mexico S.C., Guadajalara, Jalisco
Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco
Local Institution - 0010, Cuernavaca, Morelos
Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo LEON
Local Institution - 0096, Chihuahua, Not set
IMACEN S.A de C.V., Chihuahua, Not set
Oaxaca Site Management Organization, Oaxaca, Not set
Local Institution - 0100, Lima, Not set
Instituto Peruano del Hueso y la Articulación, Lima, Not set
ACQ Medic SAC - Centro de Investigación Clinica Inmunoreumatología, Lima, Not set
Local Institution - 0093, Lima, Not set
Clinica San Juan Bautista, Lima, Not set
Clinica Medica Cayetano Heredia, Lima, Not set
Local Institution - 0218, Wroclaw, Dolnośląskie
Zespół Poradni Specjalistycznych Reumed Filia nr 1 Wallenroda, Lublin, Lubelskie
Centrum Medyczne Reuma Park, Warszawa, Mazowieckie
Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Mazowieckie
Futuremeds Targowek, Warszawa, Mazowieckie
Pratia MCM Krakow, Kraków, Małopolskie
Local Institution - 0016, Elbląg, Warmińsko-mazurskie
Ortopedyczno-Rehabilitacyjny Szpital Kliniczny UM w Poznaniu, Poznan, Wielkopolskie
Centrum Wsparcia Badań Klinicznych Pomorskiego Uniwersytetu Medycznego w Szczecinie, Szczecin, Not set
MICS Centrum Medyczne Warszawa, Warszawa, Not set
Local Institution - 0031, Wroclaw, Not set
SOMED CR, Lodz, Łódzkie
M2M Med, Chorzów, Śląskie
Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon, Lisboa
Unidade Local De Saude De Gaia/Espinho E.P.E., Vila Nova de Gaia, Porto
Instituto Portugues de Reumatologia, Lisbon, Not set
Hospital Professor Doutor Fernando Fonseca, Lisbon, Not set
Local Institution - 0240, Caguas, Not set
Latin Clinical Trial Center, San Juan, Not set
Singapore General Hospital, Singapore, Not set
Local Institution - 0127, Singapore, Not set
Hospital de Mérida, Mérida, Badajoz
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Hospital Universitario Marqués de Valdecilla, Santander, Cantabria
Hospital Universitario Reina Sofia, Cordoba, Madrid
Osi Bilbao-Basurto, Bilbo, País Vasco
Local Institution - 0055, Vitoria-Gasteiz, País Vasco
Hospital Quironsalud Infanta Luisa, Sevilla, Not set
Hospital Universitario Rio Hortega, Valladolid, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung
Chung Shan Medical University Hospital, Taichung City, Taichung
China Medical University Hospital, Taichung, Not set
Taichung Veterans General Hospital, Taichung, Not set
Chi Mei Medical Center, Tainan City, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Local Institution - 0207, Bangkok, Krung Thep Maha Nakhon
Ramathibodi Hospital, Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital, Bangkok, Krung Thep Maha Nakhon
Hacettepe Universite Hastaneleri, Ankara, Not set
Akdeniz Universitesi Hastanesi, Antalya, Not set
NCR International Hospital, Gaziantep, Not set
Local Institution - 0170, Istanbul, Not set
Royal Free Hospital, London, England
Local Institution - 0236, Larbert, Falkirk
King's College Hospital, London, Greater London
Guy's & St Thomas' NHS Foundation Trust, London, London, City Of
Local Institution - 0168, Central Middlesbrough, Middlesbrough
Local Institution - 0092, Bradford, Not set
Oxford University Hospitals - Nuffield Orthopaedic Centre, Oxford, Not set
Conditions: Systemic Lupus Erythematosus
FARAPULSE Workflow Assessment Registry
Recruiting
The study is designed to determine the best practices in the patient pathway, and to analyze pre-procedural, procedural and follow-up workflow data related with ablation of atrial fibrillation where the FARAPULSE™ Pulsed Field Ablation System is used in a commercial and standard of care setting. Workflow-related variables, inclusive of pre-procedural imaging, methods of transseptal access, anesthesia/sedation technique, intracardiac mapping, ablation settings, dosing strategy, lesion sets and ge... Read More
The study is designed to determine the best practices in the patient pathway, and to analyze pre-procedural, procedural and follow-up workflow data related with ablation of atrial fibrillation where the FARAPULSE™ Pulsed Field Ablation System is used in a commercial and standard of care setting. Workflow-related variables, inclusive of pre-procedural imaging, methods of transseptal access, anesthesia/sedation technique, intracardiac mapping, ablation settings, dosing strategy, lesion sets and general procedure management, will be used to identify predominant workflow schemes that will be associated with patient demographics, procedure-related complications (safety parameters), and one-year effectiveness parameters.
The study data can be used for procedural workflow optimization when using Pulsed Field Ablation for the ablation treatment of Atrial Fibrillation based on patient demographics, cardiac anatomy and arrhythmia characteristics. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: A.o. Krankenhaus der Elisabethinen Linz, Linz, Not set +32 locations
A.o. Krankenhaus der Elisabethinen Linz, Linz, Not set
Ziekenhuis aan de Stroom, Middelheim, Antwerp, Not set
Ziekenhuis Oost-Limburg, Genk, Not set
CHR de la Citadelle, Namur, Not set
CHU de Bordeaux, Bordeaux, Not set
Hopital Saint Philibert, Lomme, Not set
CHRU Hopital Trousseau, Tours, Not set
Universitaetsklinikum Dusseldorf, Düsseldorf, Not set
Universitaetsklinikum Heidelberg, Heidelberg, Not set
Staedtisches Klinikum Karlsruhe, Karlsruhe, Not set
Munchen Klinik Bogenhausen, München, Not set
University Hospital of Muenster, Münster, Not set
Ippokrateio General Hospital of Athens, Athens, Not set
Mitera Hospital, Athens, Not set
Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Not set
Ospedale Dell Angelo, Mestre, Not set
Azienda Ospedaliera San Gerardo, Monza, Not set
Ospedale di Rivoli, Rivoli, Not set
Ospedale San Bortolo di Vicenza Azienda ULSS 8 Berica, Vicenza, Not set
Onze Lieve Vrouwe Gasthuis, Amsterdam, Not set
King Fahd Armed Forces Hospital, Jeddah, Not set
Hospital De La Santa Creu I Sant Pau, Barcelona, Not set
University Hospital Virgen Arrixaca, El Palmar, Not set
Hospital de Navarra, Pamplona, Not set
Hospital Universitario Nuestra Senora de Candelaria, Santa Cruz De Tenerife, Not set
GHP Arytmi Center Stockholm, Stockholm, Not set
Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, Not set
Royal Bournemouth Hospital, Bournemouth, Not set
Papworth Hospital, Cambridge, Not set
Glenfield Hospital, Leicester, Not set
St. Georges Hospital, London, Not set
Freeman Hospital, Newcastle Upon Tyne, Not set
Southampton University Hospital, Southampton, Not set
Conditions: Atrial Fibrillation (AF)
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Recruiting
This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical, imaging, and biospecimen data. The primary objective is to optimize progressive pulmonary fibrosis (PPF) classification and establish PPF incidence for key ILD subtypes. Additional exploratory objectives are to 1) Prospectively validate a novel PPF classifier and assess performance durability over... Read More
This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical, imaging, and biospecimen data. The primary objective is to optimize progressive pulmonary fibrosis (PPF) classification and establish PPF incidence for key ILD subtypes. Additional exploratory objectives are to 1) Prospectively validate a novel PPF classifier and assess performance durability over time, and 2) Determine whether multi-dimensional PPF prediction outperforms component approaches. Read Less
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
08/18/2025
Locations: University of Massachusetts Chan Medical School, Worcester, Massachusetts +12 locations
University of Massachusetts Chan Medical School, Worcester, Massachusetts
University of Michigan, Ann Arbor, Michigan
University of Texas Southwestern, Dallas, Texas
University of Virginia, Charlottesville, Virginia
University of Washington, Seattle, Washington
Royal Prince Alfred Hospital, Camperdown, New South Wales
Prince Charles Hospital, Brisbane, Queensland
Austin Health, Melbourne, Victoria
University of Calgary, Calgary, Alberta
University of British Columbia, Vancouver, British Columbia
University College Dublin, Dublin, Not set
Royal Brompton, London, Greater London
University Hospital Southampton, Southampton, Hampshire
Conditions: Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Recruiting
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work the same for all patients or may stop working over time. This study will evaluate the effectiveness and adverse events of targeted therapies (TaTs) for adult participants with moderate to severe CD.... Read More
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work the same for all patients or may stop working over time. This study will evaluate the effectiveness and adverse events of targeted therapies (TaTs) for adult participants with moderate to severe CD.
The medicines assessed in this study are risankizumab, ABBV-382 and lutikizumab. When participants join the study, they will be randomized into available study treatment groups. Adult participants with CD will be enrolled. Around 500 participants will be enrolled in the study at approximately 300 sites worldwide.
Risankizumab and ABBV-382 are given as an injection under the skin or as an infusion into the vein. Lutikizumab is given as an injection under the skin. Each group includes a 12-week induction period, a 12-week maintenance period, and an optional long-term extension period where medication will be given after the maintenance period.
There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, endoscopies, checking for side effects and completing questionnaires and a daily diary. Read Less
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/18/2025
Locations: Digestive Health Specialists /ID# 266216, Dothan, Alabama +222 locations
Digestive Health Specialists /ID# 266216, Dothan, Alabama
East View Medical Research /ID# 270377, Mobile, Alabama
Southern California Res. Ctr /ID# 265549, Coronado, California
UC San Diego Health System /ID# 265565, La Jolla, California
uc davis medical center - patient support services building /ID# 265554, Sacramento, California
Clinical Applications Laboratories - San Diego - 3rd Avenue /ID# 267391, San Diego, California
Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 265557, Colorado Springs, Colorado
Danbury Hospital, Western Connecticut Health Network /ID# 265556, Danbury, Connecticut
Yale University School of Medicine /ID# 266786, New Haven, Connecticut
Nature Coast Clinical Research - Inverness /ID# 265874, Inverness, Florida
Atlantic Medical Research /ID# 266207, Margate, Florida
A Plus Research /ID# 265878, Miami, Florida
Sanchez Clinical Research /ID# 265887, Miami, Florida
Advanced Research Institute, Inc /ID# 265548, New Port Richey, Florida
Hillcrest Medical Research, LLC /ID# 267237, Orange City, Florida
Endoscopic Research, Inc. /ID# 267211, Orlando, Florida
AdventHealth Medical Group - Tampa - Bruce B Downs Boulevard /ID# 265538, Tampa, Florida
Florida Medical Clinic - Zephyrhills /ID# 267392, Zephyrhills, Florida
Gastroenterology Associates of Central Georgia /ID# 265547, Macon, Georgia
Treasure Valley Medical Research /ID# 267114, Boise, Idaho
University of Chicago Medical Center /ID# 267400, Chicago, Illinois
OSF St. Francis Medical Center /ID# 266973, Peoria, Illinois
Springfield Clinic Main Campus /ID# 267434, Springfield, Illinois
University of Kentucky Chandler Medical Center /ID# 265564, Lexington, Kentucky
Metropolitan Gastroenterology Group - Chevy Chase /ID# 265877, Chevy Chase, Maryland
Lucida Clinical Trials /ID# 266548, New Bedford, Massachusetts
Henry Ford Medical Center - Columbus /ID# 266503, Novi, Michigan
Mayo Clinic-Rochester /ID# 265550, Rochester, Minnesota
GI Associates Research, LLC /ID# 267433, Columbia, Missouri
BVL Clinical Research /ID# 265870, Liberty, Missouri
Washington University School of Medicine - St. Louis /ID# 266938, Saint Louis, Missouri
Vector Clinical Trials /ID# 265561, Las Vegas, Nevada
NYU Langone Long Island Clinical Research Association /ID# 265566, Great Neck, New York
Icahn School of Medicine at Mount Sinai /ID# 266857, New York, New York
Northwell Health-Lenox Hill Hospital /ID# 265527, New York, New York
Care Access - Yonkers /ID# 266781, Yonkers, New York
Digestive Health Partners - Biltmore Office /ID# 265539, Asheville, North Carolina
Velocity Clinical Research - Durham /ID# 267712, Durham, North Carolina
University of Cincinnati /ID# 265589, Cincinnati, Ohio
The Ohio State University /ID# 265577, Columbus, Ohio
Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City, Oklahoma
Penn State Health Milton South Hershey Medical Center /ID# 267126, Hershey, Pennsylvania
University of Pennsylvania /ID# 265904, Philadelphia, Pennsylvania
Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg, South Carolina
GI associates of Northeast Tennessee /ID# 265567, Johnson City, Tennessee
Gi Alliance - Cedar Park /ID# 268153, Cedar Park, Texas
Proactive Clinical Research /ID# 267305, El Paso, Texas
Digestive Health Associates of Texas (DHAT) Research Institute - Garland /ID# 266935, Garland, Texas
Houston Methodist Hospital /ID# 265533, Houston, Texas
Caprock Gastro Research - Lubbock - 80th Street /ID# 265541, Lubbock, Texas
GI Alliance: Mansfield /ID# 266947, Mansfield, Texas
Clinical Associates in Research Therapeutics of America, LLC /ID# 265899, San Antonio, Texas
Sun Research Institute /ID# 266723, San Antonio, Texas
Texas Digestive Disease Consultants - Southlake /ID# 265576, Southlake, Texas
Tyler Research Institute, LLC /ID# 265545, Tyler, Texas
Care Access - Ogden /ID# 266428, Ogden, Utah
Care Access - Salt Lake City /ID# 266785, Salt Lake City, Utah
Washington Gastroenterology - Tacoma /ID# 267302, Tacoma, Washington
Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 265929, Linz, Oberoesterreich
Klinikum Wels-Grieskirchen GmbH /ID# 266035, Wels, Oberoesterreich
Medizinische Universitaet Graz /ID# 275453, Graz, Steiermark
Medizinische Universitaet Innsbruck /ID# 265930, Innsbruck, Tirol
Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 265928, Salzburg, Not set
Medizinische Universitaet Wien /ID# 265926, Wien, Not set
Imelda Ziekenhuis /ID# 265995, Bonheiden, Antwerpen
Universite Libre de Bruxelles - Hopital Erasme /ID# 265993, Anderlecht, Bruxelles-Capitale
CHU Saint-Pierre /ID# 266431, Brussels, Bruxelles-Capitale
Cliniques Universitaires UCL Saint-Luc /ID# 265521, Bruxelles, Bruxelles-Capitale
Groupe Sante CHC - Clinique du MontLegia /ID# 265522, Liège, Liege
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 265517, Yvoir, Namur
UZ Leuven /ID# 265519, Leuven, Vlaams-Brabant
AZ Groeninge /ID# 265544, Kortrijk, West-Vlaanderen
CHU de Liege /ID# 265542, Liege, Not set
Hospital Tsaritsa Yoanna /ID# 266235, Sofiya, Sofia
Medical Center - Doverie /ID# 267050, Sofiya, Sofia
ACIBADEM City Clinic Diagnostic-Consultative Center /ID# 266239, Sofiya, Sofia
Umbal Kaspela /ID# 266234, Plovdiv, Not set
2nd Mhat /ID# 266238, Sofia, Not set
Acibadem City Clinic Tokuda University Hospital EAD /ID# 267437, Sofia, Not set
Military Medical Academy Multiprofile Hospital /ID# 267051, Sofia, Not set
UMHAT Multiprofile Hospital for Active Treatment Sveta Marina /ID# 266237, Varna, Not set
University of Calgary /ID# 265524, Calgary, Alberta
Gastroenterology and Internal Medicine Research Institute /ID# 265610, Edmonton, Alberta
University of Alberta Hospital /ID# 265614, Edmonton, Alberta
London Health Sciences Centre - University Hospital /ID# 267298, London, Ontario
Toronto Digestive Disease Associates /ID# 267358, Vaughan, Ontario
Diex Recherche Quebec Inc. /ID# 265611, Quebec, Not set
Poliklinika Solmed /ID# 265509, Zagreb, Grad Zagreb
Poliklinika Borzan d.o.o. /ID# 265503, Osijek, Osjecko-baranjska Zupanija
Specialty Hospital Medico /ID# 265504, Rijeka, Primorsko-goranska Zupanija
Klinicki Bolnicki Centar (KBC) Split /ID# 265511, Split, Splitsko-dalmatinska Zupanija
Hepato-Gastroenterologie HK /ID# 265387, Hradec Králové, Hradec Kralove
SurGal Clinic /ID# 265388, Brno, Jihomoravsky Kraj
Iscare Klinické Centrum /ID# 265407, Prague, Praha 9
Medicum /ID# 268304, Tallinn, Harjumaa
East Tallinn Central Hospital /ID# 267658, Tallinn, Not set
Tartu University Hospital /ID# 267656, Tartu, Not set
Chu de Nice-Hopital L'Archet Ii /Id# 267478, Nice, Alpes-Maritimes
Centre Hospitalier Universitaire de Bordeaux /ID# 265721, Pessac CEDEX, Gironde
CHU de Toulouse - Hôpital Rangueil /ID# 267479, Toulouse CEDEX 9, Haute-Garonne
CHU de Montpellier - Hopital Saint Eloi /ID# 265718, Montpellier, Herault
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou /ID# 266848, Rennes, Ille-et-Vilaine
Centre Hospitalier Universitaire de Saint Etienne - Hopital Nord /ID# 265340, St-Priest-en-Jarez, Loire
CHRU de Nancy-Hopital Brabois Adultes /ID# 265703, Vandoeuvre les Nancy, Lorraine
Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud /ID# 266851, Pierre Benite, Rhone
Clinique Jules Verne /ID# 267480, Nantes, Not set
Hôpital Saint Antoine /ID# 265725, Paris, Not set
Universitaetsklinikum Freiburg /ID# 265755, Freiburg, Baden-Wuerttemberg
Universitaetsmedizin Mannheim /ID# 266961, Mannheim, Baden-Wuerttemberg
Universitaetsklinikum Ulm /ID# 266962, Ulm, Baden-Wuerttemberg
Universitaetsklinikum Erlangen /ID# 265927, Erlangen, Bayern
Markus Krankenhaus /ID# 265938, Frankfurt am Main, Hessen
Universitaetsklinikum Frankfurt /ID# 266827, Frankfurt, Hessen
Klinikum Lueneburg /ID# 266886, Lueneburg, Niedersachsen
St. Marien- und St. Annastiftskrankenhaus /ID# 265912, Ludwigshafen am Rhein, Rheinland-Pfalz
Universitaetsklinikum des Saarlandes /ID# 265753, Homburg, Saarland
Studiengesellschaft BSF Unternehmergesellschaft /ID# 265751, Halle (Saale), Sachsen-Anhalt
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 265931, Dresden, Sachsen
Eugastro /ID# 266826, Leipzig, Sachsen
Universitaetsklinikum Schleswig-Holstein - Campus Kiel /ID# 265738, Kiel, Schleswig-Holstein
Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 267254, Lübeck, Schleswig-Holstein
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 265752, Berlin, Not set
DRK Kliniken Berlin - Westend /ID# 265925, Berlin, Not set
Krankenhaus Waldfriede /ID# 266676, Berlin, Not set
Debreceni Egyetem-Klinikai Kozpont /ID# 267389, Debrecen, Hajdu-Bihar
Clinfan /ID# 267385, Szekszárd, Tolna
Synexus Hungary Clinical Research Centre - Budapest /ID# 267384, Budapest, Not set
Semmelweis Egyetem /ID# 267064, Budapest, Not set
Semmelweis Egyetem /ID# 267068, Budapest, Not set
Szegedi Tudományegyetem /ID# 267386, Szeged, Not set
Portiuncula University Hospital /ID# 267771, Ballinasloe, Galway
Our Lady of Lourdes Hospital - Drogheda /ID# 267768, Drogheda, Louth
Midland Regional Hospital Mullingar /ID# 267769, Mullingar, Westmeath
St. Vincent's University Hospital /ID# 267766, Dublin, Not set
Beaumont Hospital /ID# 267770, Dublin, Not set
Connolly Hospital /ID# 268021, Dublin, Not set
Soroka Medical Center /ID# 267235, Be'er Sheva, HaDarom
Edith Wolfson Medical Center /ID# 267640, Holon, HaMerkaz
Tel Aviv Sourasky Medical Center /ID# 267307, Tel Aviv, Tel-Aviv
Rambam Health Care Campus /ID# 267641, Haifa, Not set
Azienda Ospedaliero Universitaria di Cagliari - P.O. Duilio Casula /ID# 267287, Monserrato, Cagliari
Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 267143, San Giovanni Rotondo, Foggia
IRCCS Istituto Clinico Humanitas /ID# 265946, Rozzano, Lombardia
IRCCS Ospedale San Raffaele /ID# 265951, Milan, Milano
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 265935, Rome, Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 265940, Rome, Roma
A.O. Ordine Mauriziano di Torino /ID# 267144, Turin, Torino
IRCCS Ospedale Sacro Cuore Don Calabria /ID# 265942, Negrar, Verona
Azienda Ospedaliero-Universitaria Renato Dulbecco /ID# 267722, Catanzaro, Not set
Azienda Ospedaliera Universitaria Gaetano Martino /ID# 267145, Messina, Not set
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 265949, Milano, Not set
Inje University Haeundae Paik Hospital /ID# 266380, Busan, Busan Gwang Yeogsi
Dong-A University Medical Center /ID# 266709, Busan, Busan Gwang Yeogsi
The Catholic University of Korea, Daejeon St. Mary's Hospital /ID# 265488, Daejeon, Daejeon Gwang Yeogsi
Chungang University Hospital /ID# 266427, Dongjak-gu, Seoul Teugbyeolsi
Samsung Medical Center /ID# 265489, Seoul, Seoul Teugbyeolsi
Kyungpook National University Chilgok Hospital /ID# 265487, Daegu, Not set
Liepaja Regional Hospital /ID# 267703, Liepaja, Not set
Pauls Stradins Clinical University Hospital /ID# 267705, Riga, Not set
Digestive Diseases Center GASTRO /ID# 267707, Riga, Not set
Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 267695, Kaunas, Not set
Panevezys Republican Hospital /ID# 267709, Panevezys, Not set
Vilnius University Hospital Santaros Klinikos /ID# 267711, Vilnius, Not set
Elisabeth TweeSteden Ziekenhuis /ID# 265729, Tilburg, Noord-Brabant
Amsterdam UMC, locatie AMC /ID# 268321, Amsterdam, Noord-Holland
Universitair Medisch Centrum Groningen /ID# 265736, Groningen, Not set
Universitair Medisch Centrum Utrecht /ID# 265731, Utrecht, Not set
Akershus University Hospital /ID# 267642, Lørenskog, Akershus
Helse More- og Romsdal HF, Alesund sjukehus /ID# 267632, Alesund, More Og Romsdal
Oslo Universitetssykehus Ulleval /ID# 267630, Oslo, Not set
NZOZ Centrum Medyczne KERmed /ID# 266766, Bydgoszcz, Kujawsko-pomorskie
Gastromed Sp. z o.o /ID# 266765, Torun, Kujawsko-pomorskie
Malopolskie Centrum Kliniczne /ID# 265943, Krakow, Malopolskie
Medical Network Sp.z.o.o. WIP Warsaw IBD Point Profesor Kierkus /ID# 266764, Warsaw, Mazowieckie
Bodyclinic Sp. z o.o. sp.k. /ID# 265945, Warszawa, Mazowieckie
Endoskopia Sp. z.o.o. /ID# 265934, Sopot, Pomorskie
H-T Centrum Medyczne Endoterapia /ID# 265937, Tychy, Slaskie
Polimedica PTG Kielce /ID# 267066, Kielce, Swietokrzyskie
Unidade Local de Saude do Alto Ave, EPE /ID# 265892, Guimaraes, Braga
2CA-Braga, Hospital de Braga /ID# 265894, Braga, Not set
Unidade Local de Saude de Coimbra, EPE /ID# 267240, Coimbra, Not set
Unidade Local de Saude de Lisboa Ocidental, EPE /ID# 267242, Lisboa, Not set
Unidade Local de Saude de Santa Maria, EPE /ID# 266113, Lisboa, Not set
Unidade Local de Saude do Alto Minho, EPE - Hospital de Santa Luzia /ID# 265885, Viana Do Castelo, Not set
Memorial Healthcare International S.R.L. /Id# 267328, Bucharest, Bucuresti
Spitalul Clinic Colentina /ID# 267208, Bucharest, Bucuresti
Clinica Gastro Med SRL /ID# 267204, Cluj-Napoca, Cluj
OncoHelp Association /ID# 267203, Timișoara, Timis
Clinical Hospital Center Zvezdara /ID# 265605, Belgrade, Beograd
Military Medical Academy /ID# 267452, Belgrade, Beograd
University Clinical Hospital Center "Dr. Dragisa Misovic - Dedinje" /ID# 265607, Belgrade, Beograd
Clinical Hospital Center - Bežanijska Kosa /ID# 265604, Belgrade, Beograd
Leskovac General Hospital /ID# 265606, Leskovac, Jablanicki Okrug
General Hospital Djordje Joanovic /ID# 266040, Zrenjanin, Vojvodina
University Clinical Center Vojvodina /ID# 265603, Novi Sad, Not set
Mount Elizabeth Hospital /ID# 268354, Singapore, Central Singapore
Gleneagles Hospital /ID# 268385, Singapore, Central Singapore
National University Hospital /ID# 268128, Singapore, Not set
Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 266064, Banska Bystrica, Banskobystricky Kraj
KM Management, spol. s.r.o. /ID# 266070, Nitra, Nitriansky Kraj
Gastro I., s.r.o. /ID# 267159, Prešov, Presovsky Kraj
ENDOMED s.r.o /ID# 266068, Košice, Not set
General Hospital Celje /ID# 267699, Celje, Not set
University Medical Centre Ljubljana /ID# 267697, Ljubljana, Not set
Complejo Hospitalario Universitario de Santiago (CHUS) /ID# 266902, Santiago de Compostela, A Coruna
Hospital Universitario Virgen Macarena /ID# 266648, Seville, Sevilla
Hospital Universitario Virgen del Rocio /ID# 266727, Seville, Sevilla
Hospital Clinic de Barcelona /ID# 265415, Barcelona, Not set
Hospital Universitario 12 de Octubre /ID# 265444, Madrid, Not set
Hospital Universitario La Paz /ID# 265412, Madrid, Not set
Hospital Alvaro Cunqueiro /ID# 266647, Pontevedra, Not set
Hospital Universitari i Politècnic La Fe /ID# 265478, Valencia, Not set
Intesto /ID# 265728, Bern, Not set
Western General Hospital - NHS Lothian /ID# 266333, Edinburgh, Edinburgh, City Of
Gartnavel General Hospital /ID# 266407, Glasgow, Glasgow City
Royal Free Hospital /ID# 268065, London, Greater London
Guy's Hospital /ID# 266336, London, Greater London
St George's University Hospitals NHS Foundation Trust /ID# 266335, London, Greater London
The John Radcliffe Hospital /ID# 266334, Oxford, Oxfordshire
The Royal Wolverhampton NHS Trust /ID# 268158, Guildford, Surrey
University Hospital Coventry & Warwickshire NHS Trust /ID# 267128, Coventry, Warwickshire
Barts Health NHS Trust /ID# 266410, London, Not set
Royal Victoria Infirmary /ID# 268064, Newcastle upon Tyne, Not set
Conditions: Crohn's Disease
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Recruiting
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults with recently diagnosed severe acute respiratory syndrome - coronavirus 2 (SARS-CoV2) infection who do not require hospitalization. The primary endpoint of this double-blind randomized trial is a five-category ordinal outcome that asse... Read More
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults with recently diagnosed severe acute respiratory syndrome - coronavirus 2 (SARS-CoV2) infection who do not require hospitalization. The primary endpoint of this double-blind randomized trial is a five-category ordinal outcome that assesses the participant's clinical status seven days after the infusion of hIVIG or placebo.
1. Asymptomatic and no limitations in usual activity due to COVID-19
2. Mild COVID-19 illness or minor limitations to usual activity
3. Moderate COVID-19 illness and with major limitations to usual activity
4. Severe COVID-19 or serious disease manifestation from COVID-19
5. Critical illness from COVID-19 or Death
Two strata of participants will be identified for analysis purposes. Stratum 2 will be participants who receive direct-acting antivirals (DAAs) or other anti-SARS-CoV2 agents that are approved/available and recommended for use as part of standard of care (SOC), estimated to be about 20% of participants. Stratum 1 will be participants who do not receive this agents, estimated to be about 80% of participants. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: Southern Arizona VA Healthcare System (074-009), Tucson, Arizona +61 locations
Southern Arizona VA Healthcare System (074-009), Tucson, Arizona
VA Northern California Health Care System (074-023), Mather, California
Stanford University Hospital & Clinics (Site 203-003), Palo Alto, California
San Francisco VAMC (Site 074-002), San Francisco, California
Rocky Mountain Regional VA Medical Center (074-010), Aurora, Colorado
MedStar Health Research Institute, Washington, District of Columbia
Washington DC Veterans Affairs Medical Center, Washington, District of Columbia
University of Maryland Medical System, Baltimore, Maryland
Henry Ford Health System Site (014-001), Detroit, Michigan
Infusion Associates, Grand Rapids, Michigan
Mount Sinai Beth Israel Hospital, New York, New York
Icahn School of Medicine at Mount Sinai, New York, New York
Cleveland Clinic Foundation (Site 207-001), Cleveland, Ohio
Penn State Health Milton S. Hershey Medical Center (209-002), Hershey, Pennsylvania
Hendrick Medical Center, Abilene, Texas
CHRISTUS Spohn Shoreline Hospital, Corpus Christi, Texas
UT Southwestern Medical Center, Dallas, Texas
Intermountain Medical Center (211-001), Murray, Utah
Carilion Medical Center (Site 080-018), Roanoke, Virginia
Salem VA Medical Center (074-014), Salem, Virginia
Swedish Hospital First Hill, Seattle, Washington
Instituto Medico Platense, La Plata, Buenos Aires
Centro de Investigaciones Medicas de Mar del Plata (Site 611-031), Mar del Plata, Buenos Aires
Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Not set
St. Vincent's Hospital, Sydney, New South Wales
Odense University Hospital, Odense, C
Aarhus Universitetshospital, Skejby, Aarhus, N
Department of Infectious Diseases, Aalborg, Not set
Rigshospitalet, CHIP, Copenhagen, Not set
Bispebjerg Hospital, Copenhagen, Not set
Herlev/Gentofte Hospital, Hellerup, Not set
Hvidovre University Hospital, Department of Infectious Diseases, Hvidovre, Not set
Kolding Sygehus, Kolding, Not set
Dept of Critical Care and Pulmonary Medicine, Evangelismos General Hospital, Athens, Attica
3rd Dept of Medicine, Medical School, Athens, Attica
Laiko Athens General Hospital, Athens, Attica
Department of Clinical Therapeutics of Alexandra Hospital, Athens, Attica
4th Department of Internal Medicine, Athens, Attica
All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Not set
Hospital General Dr. Manuel Gea Gonzáles, Mexico City, Cdmx
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Cdmx
Instituto Nacional de Enfermedades Respiratorias Ismael Cosió Villegas, Mexico City, Cdmx
CHRISTUS Centro de Excelencia en Investigacion (Obispado), Monterrey, NL
Hospital General Dr. Aurelio Valdivieso, Oaxaca City, OA
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona
CAP Can Bou, Castelldefels, Barcelona
CAP El Maresme, Mataro, Barcelona
CAP Corbera, Barcelona, Not set
Siriraj Hospital (Site 613-002), Bangkok Noi, Bangkok
Chulalongkorn University and The HIV-NAT, Pathum Wan, Bangkok
Khon Kaen University, Srinagarind Hospital (Site 613-003), Khon Kaen, Not set
Bamrasnaradura Infections Diseases Institute (613-007), Nonthaburi, Not set
MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Not set
Joint Clinical Research Center (JCRC), Kampala, Not set
Makerere University Lung Institute (Site 634-604), Kampala, Not set
St. Francis Hospital, Nsambya, Kampala, Not set
Lira Regional Referral Hospital, Lira, Not set
Masaka Regional Referral Hospital, Masaka, Not set
Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivs'k, Not set
University College London Hospitals, London, Not set
Royal Victoria Infirmary, Newcastle upon Tyne, Not set
Conditions: COVID, SARS-CoV2 Infection, Covid19
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Recruiting
This is a randomised, placebo-controlled, double-blind study to assess the efficacy and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma.
This is a randomised, placebo-controlled, double-blind study to assess the efficacy and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma. Read Less
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
08/18/2025
Locations: Research Site, Birmingham, Alabama +391 locations
Research Site, Birmingham, Alabama
Research Site, Sheffield, Alabama
Research Site, Phoenix, Arizona
Research Site, Tucson, Arizona
Research Site, Little Rock, Arkansas
Research Site, Bakersfield, California
Research Site, Fountain Valley, California
Research Site, Fullerton, California
Research Site, Huntington Beach, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Newport Beach, California
Research Site, San Diego, California
Research Site, San Jose, California
Research Site, Valencia, California
Research Site, Vista, California
Research Site, Colorado Springs, Colorado
Research Site, Clearwater, Florida
Research Site, Coral Gables, Florida
Research Site, Cutler Bay, Florida
Research Site, Cutler Bay, Florida
Research Site, Hialeah, Florida
Research Site, Hialeah, Florida
Research Site, Hialeah, Florida
Research Site, Hialeah, Florida
Research Site, Hollywood, Florida
Research Site, Miami Springs, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Miami, Florida
Research Site, Orlando, Florida
Research Site, Palmetto Bay, Florida
Research Site, Tallahassee, Florida
Research Site, Tampa, Florida
Research Site, Tampa, Florida
Research Site, Tampa, Florida
Research Site, Atlanta, Georgia
Research Site, Fayetteville, Georgia
Research Site, Lithonia, Georgia
Research Site, Savannah, Georgia
Research Site, Boise, Idaho
Research Site, Chicago, Illinois
Research Site, Skokie, Illinois
Research Site, Indianapolis, Indiana
Research Site, Leawood, Kansas
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Owensboro, Kentucky
Research Site, Oxon Hill, Maryland
Research Site, Boston, Massachusetts
Research Site, New Bedford, Massachusetts
Research Site, Ann Arbor, Michigan
Research Site, Buckley, Michigan
Research Site, Farmington Hills, Michigan
Research Site, Lathrup Village, Michigan
Research Site, Rochester, Minnesota
Research Site, Saint Charles, Missouri
Research Site, Saint Louis, Missouri
Research Site, Saint Louis, Missouri
Research Site, Bellevue, Nebraska
Research Site, Las Vegas, Nevada
Research Site, East Orange, New Jersey
Research Site, Toms River, New Jersey
Research Site, Bronx, New York
Research Site, Bronx, New York
Research Site, Horseheads, New York
Research Site, Valhalla, New York
Research Site, Charlotte, North Carolina
Research Site, Charlotte, North Carolina
Research Site, Gastonia, North Carolina
Research Site, Wilmington, North Carolina
Research Site, Fargo, North Dakota
Research Site, Blue Ash, Ohio
Research Site, Blue Ash, Ohio
Research Site, Dayton, Ohio
Research Site, Oakwood, Ohio
Research Site, Toledo, Ohio
Research Site, Edmond, Oklahoma
Research Site, Oklahoma City, Oklahoma
Research Site, Altoona, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Columbia, South Carolina
Research Site, Greenville, South Carolina
Research Site, Greenville, South Carolina
Research Site, Rock Hill, South Carolina
Research Site, Spartanburg, South Carolina
Research Site, Austin, Texas
Research Site, Austin, Texas
Research Site, Beaumont, Texas
Research Site, Bellaire, Texas
Research Site, Boerne, Texas
Research Site, Dallas, Texas
Research Site, El Paso, Texas
Research Site, El Paso, Texas
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, McAllen, Texas
Research Site, McKinney, Texas
Research Site, Pearland, Texas
Research Site, San Antonio, Texas
Research Site, Sugar Land, Texas
Research Site, Tomball, Texas
Research Site, Wylie, Texas
Research Site, Milwaukee, Wisconsin
Research Site, Bahia Blanca, Not set
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, Capital Federal, Not set
Research Site, Ciudad Capital, Not set
Research Site, Ciudad de Buenos Aire, Not set
Research Site, Concepción del Uruguay, Not set
Research Site, Córdoba, Not set
Research Site, Florencio Varela, Not set
Research Site, Florida, Not set
Research Site, Godoy Cruz, Not set
Research Site, La Plata, Not set
Research Site, La Plata, Not set
Research Site, Lobos, Not set
Research Site, Mar del Plata, Not set
Research Site, Mar del Plata, Not set
Research Site, Mendoza, Not set
Research Site, Mendoza, Not set
Research Site, Mendoza, Not set
Research Site, Pilar, Not set
Research Site, Quilmes, Not set
Research Site, Ramos Mejía, Not set
Research Site, Rosario, Not set
Research Site, San Miguel de Tucuman, Not set
Research Site, Santa Fe, Not set
Research Site, Adelaide, Not set
Research Site, Clayton, Not set
Research Site, Mitcham, Not set
Research Site, South Brisbane, Not set
Research Site, Kozloduy, Not set
Research Site, Montana, Not set
Research Site, Plovdiv, Not set
Research Site, Ruse, Not set
Research Site, Sliven, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Stara Zagora, Not set
Research Site, Velingrad, Not set
Research Site, Vidin, Not set
Research Site, La Serena, Not set
Research Site, Quillota, Not set
Research Site, Santiago de Chile, Not set
Research Site, Santiago, Not set
Research Site, Santiago, Not set
Research Site, Santiago, Not set
Research Site, Santiago, Not set
Research Site, Talca, Not set
Research Site, Temuco, Not set
Research Site, Vitacura, Not set
Research Site, Viña del Mar, Not set
Research Site, Klenovnik, Not set
Research Site, Petrinja, Not set
Research Site, Rijeka, Not set
Research Site, Split, Not set
Research Site, Zabok, Not set
Research Site, Zagreb, Not set
Research Site, Zagreb, Not set
Research Site, Bordeaux, Not set
Research Site, Montpellier Cedex 5, Not set
Research Site, Saint-Herblain, Not set
Research Site, Strasbourg, Not set
Research Site, Toulouse, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Frankfurt, Not set
Research Site, Großhansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Leipzig, Not set
Research Site, Lübeck, Not set
Research Site, Marburg, Not set
Research Site, Schleswig, Not set
Research Site, Wiesbaden, Not set
Research Site, Balassagyarmat, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Gyula, Not set
Research Site, Gödöllő, Not set
Research Site, Hajdúnánás, Not set
Research Site, Kistarcsa, Not set
Research Site, Nyíregyháza, Not set
Research Site, Pécs, Not set
Research Site, Püspökladány, Not set
Research Site, Szombathely, Not set
Research Site, Battipaglia (SA), Not set
Research Site, Bergamo, Not set
Research Site, Bologna, Not set
Research Site, Ferrara, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Monza, Not set
Research Site, Napoli, Not set
Research Site, Negrar, Not set
Research Site, Reggio Emilia, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Siena, Not set
Research Site, Verona, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka, Not set
Research Site, Gifu, Not set
Research Site, Himeji, Not set
Research Site, Kawachinagano-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Kodaira-shi, Not set
Research Site, Koga-shi, Not set
Research Site, Kokubunji-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Nagaoka-shi, Not set
Research Site, Nakagun, Not set
Research Site, Nankoku-shi, Not set
Research Site, Niigata, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Sagamihara-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Setagaya-ku, Not set
Research Site, Shibuya-Ku, Not set
Research Site, Tokyo, Not set
Research Site, Tokyo, Not set
Research Site, Toshima-ku, Not set
Research Site, Toshima-ku, Not set
Research Site, Toshima-ku, Not set
Research Site, Yokkaichi-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Incheon, Not set
Research Site, Jeonju, Not set
Research Site, Seongnam-si, Not set
Research Site, Seongnam, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Chihuahua, Not set
Research Site, Chihuahua, Not set
Research Site, Chihuahua, Not set
Research Site, Guadalajara, Not set
Research Site, Guadalajara, Not set
Research Site, Guadalajara, Not set
Research Site, León, Not set
Research Site, Merida, Not set
Research Site, Mexico, Not set
Research Site, Monterrey, Not set
Research Site, Veracruz, Not set
Research Site, Zapopan, Not set
Research Site, Breda, Not set
Research Site, Eindhoven, Not set
Research Site, Groningen, Not set
Research Site, Zutphens, Not set
Research Site, Białystok, Not set
Research Site, Gdańsk, Not set
Research Site, Gdynia, Not set
Research Site, Grudziadz, Not set
Research Site, Katowice, Not set
Research Site, Katowice, Not set
Research Site, Kielce, Not set
Research Site, Krakow, Not set
Research Site, Kraków, Not set
Research Site, Ksawerów, Not set
Research Site, Ostrowiec Świętokrzyski, Not set
Research Site, Ostróda, Not set
Research Site, Poznań, Not set
Research Site, Rzeszów, Not set
Research Site, Tarnów, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Wrocław, Not set
Research Site, Wrocław, Not set
Research Site, Łódź, Not set
Research Site, Łódź, Not set
Research Site, Łódź, Not set
Research Site, Baia Mare, Not set
Research Site, Brasov, Not set
Research Site, Brasov, Not set
Research Site, Brasov, Not set
Research Site, Bucharest, Not set
Research Site, Bucuresti, Not set
Research Site, Bucuresti, Not set
Research Site, Bucuresti, Not set
Research Site, Caracal, Not set
Research Site, Cluj-Napoca, Not set
Research Site, Cluj-Napoca, Not set
Research Site, Constanta, Not set
Research Site, Deva, Not set
Research Site, Iasi, Not set
Research Site, Oradea, Not set
Research Site, Resca, Com. Dobrosloveni, Not set
Research Site, Timisoara, Not set
Research Site, Timisoara, Not set
Research Site, Belgrade, Not set
Research Site, Belgrade, Not set
Research Site, Belgrade, Not set
Research Site, Belgrade, Not set
Research Site, Nis, Not set
Research Site, Sremska Kamenica, Not set
Research Site, Uzice, Not set
Research Site, Valjevo, Not set
Research Site, Humenne, Not set
Research Site, Kezmarok, Not set
Research Site, Kosice, Not set
Research Site, Kosice, Not set
Research Site, Levice, Not set
Research Site, Presov, Not set
Research Site, Surany, Not set
Research Site, Topolcany, Not set
Research Site, Golnik, Not set
Research Site, Jesenice, Not set
Research Site, Kamnik, Not set
Research Site, Ljubljana, Not set
Research Site, Cape Town, Not set
Research Site, Centurion, Not set
Research Site, Germiston, Not set
Research Site, Johannesburg, Not set
Research Site, Krugersdorp, Not set
Research Site, Lenasia, Not set
Research Site, Mount Edgecombe, Not set
Research Site, Thohoyandou, Not set
Research Site, Vereeniging, Not set
Research Site, A Coruña, Not set
Research Site, Badalona, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Benalmádena, Not set
Research Site, Jerez de la Frontera, Not set
Research Site, Laredo, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Marbella, Not set
Research Site, Málaga, Not set
Research Site, Mérida, Not set
Research Site, Sagunto(Valencia), Not set
Research Site, Xàtiva, Not set
Research Site, Ankara, Not set
Research Site, Bursa, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Research Site, Samsun, Not set
Research Site, Samsun, Not set
Research Site, Chernivtsі, Not set
Research Site, Ivano-Frankivsk, Not set
Research Site, Kyiv, Not set
Research Site, Vinnytsia, Not set
Research Site, Vinnytsia, Not set
Research Site, Vinnytsya, Not set
Research Site, Belfast, Not set
Research Site, Birmingham, Not set
Research Site, Bradford, Not set
Research Site, Cardiff, Not set
Research Site, Chorley, Not set
Research Site, Corby, Not set
Research Site, Cottingham, Not set
Research Site, Glasgow, Not set
Research Site, Harefield, Not set
Research Site, Hexham, Not set
Research Site, Leeds, Not set
Research Site, Leicester, Not set
Research Site, Liverpool, Not set
Research Site, Liverpool, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Norwich, Not set
Research Site, Portsmouth, Not set
Research Site, Reading, Not set
Research Site, Wakefield, Not set
Research Site, Watford, Not set
Conditions: Asthma
A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function
Recruiting
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.
Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.
Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements. Read Less
Gender:
ALL
Ages:
Between 35 years and 65 years
Trial Updated:
08/18/2025
Locations: Cutest Systems Ltd, Cardiff, Not set
Cutest Systems Ltd, Cardiff, Not set
Conditions: Skin Health
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
Recruiting
This study is researching an experimental treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on people with paroxysmal nocturnal hemoglobinuria (PNH). The aim of this study is to see how safe and effective the pozelimab + cemdisiran combination is for people with PNH in the long term. The pozelimab + cemdisiran combination may be referred to as "study drugs" in this section.
This study is looking at several other research questions, including... Read More
This study is researching an experimental treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on people with paroxysmal nocturnal hemoglobinuria (PNH). The aim of this study is to see how safe and effective the pozelimab + cemdisiran combination is for people with PNH in the long term. The pozelimab + cemdisiran combination may be referred to as "study drugs" in this section.
This study is looking at several other research questions, including:
* How effective is the pozelimab + cemdisiran combination?
* What side effects may happen from taking the study drugs?
* How much of each study drug is in the blood at different times?
* Whether the body makes antibodies against the study drugs (which could make the drugs less effective or could lead to side effects) Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: Toronto General Hospital, Toronto, Ontario +35 locations
Toronto General Hospital, Toronto, Ontario
Semmelweis University/Semmelweis Egyetem, Budapest, Not set
Rajiv Gandhi Cancer Institute & Research Center (RGCIRC) - Rohini Campus, New Delhi, Delhi
Amrita Institute of Medical Sciences (AIMS) and Research Centre Aims, Kochi, Kerala
Bhagwan Mahaveer Cancer Hospital and Research Centre (BMCHRC), Jaipur, Not set
Aou Careggi, Firenze, Florence
SC Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Not set
University of Tsukuba Hospital, Tsukuba, Ibaraki
Ajou University Medical Center, Suwon-si, Gyeonggi-do
St. Vincent Hospital, Suwon, Gyeonggi
Gachon University Gil Medical Center, Incheon, Namdong-Gu
Pusan National University Hospital, Busan, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Ewha Womans University Mokdong Hospital, Seoul, Not set
Hospital Tg Ampuan Afzan, Kuantan, Pahang
Hospital Queen Elizabeth, Kota Kinabalu, Sabah
Hospital Ampang, Ampang, Selangor
Clinica San Felipe, Lima, Not set
St Lukes Medical Center, Quezon City, National Capital Region
Szpital Uniwersytecki Nr2 Bydgoszcz, Bydgoszcz, Not set
Prof Dr Ion Chiricuta Cancer Institute, Cluj Napoca, Cluj
National University Hospital, Singapore, Not set
Hospital Universitario Basurto, Bilbao, Bizkaia
Hospital Clinic de Barcelona, Barcelona, Not set
Chang Gung Memorial Hospital - Linkou Branch, Taoyuan, Hunan Province
Hualien Tzu Chi Hospital, Hualien City, Not set
China Medical University Hospital, Taichung, Not set
Tri-Service General Hospital, Taipei City, Not set
National Taiwan University Hospital, Taipei, Not set
Prince Of Songkla Hospital, Prince Of Songkhla University, Hat-Yai, Songkhla
King Chulalongkorn Memorial Hospital, Bangkok, Not set
Chiang Mai University, Chiang Mai, Not set
Srinagarind Hospital, Khon Kaen, Not set
Ege University Faculty of Medicine, Bornova, Izmir
Leeds Teaching Hospitals NHS Trust - St. James Institute of Oncology, Leeds, Not set
Conditions: Paroxysmal Nocturnal Hemoglobinuria
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Recruiting
The purpose of this study is to evaluate the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and modified leucovorin, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (mFOLFIRINOX) versus mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer treatment for PDAC and have no evidence of disease after surgery.
The purpose of this study is to evaluate the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and modified leucovorin, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (mFOLFIRINOX) versus mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer treatment for PDAC and have no evidence of disease after surgery. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/18/2025
Locations: USC Norris Comprehensive Cancer Center, Los Angeles, California +84 locations
USC Norris Comprehensive Cancer Center, Los Angeles, California
University of California Los Angeles, Los Angeles, California
USC Norris Cancer Center, Newport Beach, California
University of California, San Francisco (UCSF), San Francisco, California
St. Francis Hospital and Medical Center, Hartford, Connecticut
Smilow Cancer Center, New Haven, Connecticut
Yale Cancer Center, New Haven, Connecticut
Smilow Cancer Hospital Care Center at Trumbull, Trumbull, Connecticut
Northwestern Memorial Hospital, Chicago, Illinois
Indiana University Health Melvin & Bren Simon Cancer Center, Indianapolis, Indiana
University of Kentucky Medical Center, Lexington, Kentucky
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center, Boston, Massachusetts
Boston Medical Center (BMC) - Cancer Care Center, Boston, Massachusetts
Henry Ford Health System, Detroit, Michigan
University of Nebraska, Omaha, Nebraska
Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge, New Jersey
Memorial Sloan Kettering Cancer Center, Middletown, New Jersey
Memorial Sloan Kettering Cancer Center at Bergen, Montvale, New Jersey
Memorial Sloan Kettering Cancer Center - Commack, Commack, New York
Memorial Sloan Kettering Cancer Center at Westchester, Harrison, New York
Northwell Health, Lake Success, New York
NYU Langone Health, New York, New York
Mount SInai Medical Center, New York, New York
Columbia University Medical Center, New York, New York
MEETH-LHH Northwell Health Cancer Clinical Trials Office at MEETH-LHH, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Memorial Sloan Kettering Cancer Center at Nassau, Uniondale, New York
Duke Cancer Institute, Durham, North Carolina
University of Cincinnati Cancer Institute, Cincinnati, Ohio
Rhode Island Hospital, Providence, Rhode Island
Miriam Hospital, Providence, Rhode Island
Fred Hutchinson Cancer Research Center, Seattle, Washington
ULB Hôpital Erasme, Brussels, Not set
Antwerp University Hospital, Edegem, Not set
AZ Maria Middelares, Gent, Not set
Universitair Ziekenhuis Gent, Gent, Not set
UZ Leuven, Leuven, Not set
St Michael Hospital, Toronto, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec
Jewish General Hospital, Montreal, Quebec
Centre Hospitalier Régional Universitaire de Lille, Lille, Not set
Centre Leon Berard, Lyon, Not set
Institut Paoli Calmettes, Marseille, Not set
Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy, Not set
Gustave Roussy, Villejuif, Not set
Charite-Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK), Berlin, Not set
Universitaetsklinikum der Ruhr-Universitaet Bochum (UKRUB), Bochum, Not set
Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Universitätsklinikum Essen, Essen, Not set
Krankenhaus Nordwest GmbH, Frankfurt, Not set
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Not set
Universitaetsklinikum Heidelberg, Heidelberg, Not set
Universitaetsklinikum Koeln, Koeln, Not set
Universitaetsklinikum Tuebingen, Tuebingen, Not set
Universitätsklinikum Ulm, Klinik für Innere MedizinInnere Medizin III Studienzentrale, Ulm, Not set
National Cancer Center (NCC) Hospital - Center for Liver and Pancreatobiliary Cancer, Goyang-si, Not set
CHA Bundang Medical Center, Gyeonggi-do, Not set
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital), Seocho, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Severance Hospital - Yonsei Cancer Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC), Songpa-gu, Not set
Amsterdam UMC Location VUMC, Amsterdam, Not set
Erasmus MC, Rotterdam, Not set
Hospital Universitario Central de Asturias, Oviedo, Asturias
Institut Catala d?Oncologia Hospital Germans Trias i Pujol, Badalona, Barcelona
Hospital Regional Universitario de Malaga, Málaga, Malaga
Clinica Universitaria de Navarra (CUN), Pamplona/iruña, Navarra
Hospital Universitario Vall d Hebron, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Clinica Universitaria de Navarra de Madrid;Servicio de Hepatologia, Madrid, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
Hospital Universitario 12 De Octubre, Madrid, Not set
Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, Not set
Sahlgrenska Universitetssjukhuset, Gothenburg, Not set
Karolinska Universitetssjukhuset, Solna, Not set
Belfast City Hospital, Belfast, Not set
University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set
Addenbrookes Hospital, Cambridge, Not set
Royal Liverpool University Hospital, Liverpool, Not set
Barts Health NHS Trust, London, Not set
Guys Hospital, London, Not set
Hammersmith Hospital, London, Not set
University College London Cancer Institute, London, Not set
Conditions: Adenocarcinoma, Pancreatic Ductal
145 - 156 of 3097